Sectors
TRAW
Traws Pharma, Inc.
0.56
10 x 0.53
3 x 0.57
bid
ask
-
0.04
7.07%
01:13 PM
timesize
| Ytd | -50.12% | |
| 1y | -65.20% |
0.54
day range
0.57
0.60
52 week range
3.27
| Open | 0.57 | Prev Close | 0.61 | Low | 0.54 | High | 0.57 | Mkt Cap | 5.54M |
| Vol | 154.16K | Avg Vol | 2.33M | EPS | -1.24 | P/E | -0.49 | Forward P/E | -0.47 |
| Beta | 1.51 | Short Ratio | 0.62 | Inst. Own | 21.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.15 | 200-d Avg | 1.75 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 6.95M | ||
| Research and Development Expense | 4.91M | ||
| Selling, General and Administrative Expense | 2.03M | ||
| Operating Income | -6.95M | ||
| Net Income | -5.69M | ||
| Net Income Common Stock | -5.69M | ||
| Net Income Common Stock (USD) | -5.69M | ||
| Consolidated Income | -7.11M | ||
| Net Income to Non-Controlling Interests | -1.41M | ||
| Earnings per Basic Share | -0.53 | ||
| Earnings per Basic Share (USD) | -0.53 | ||
| Earnings per Diluted Share | -0.53 | ||
| Earning Before Interest & Taxes (EBIT) | -5.69M | ||
| Earning Before Interest & Taxes (USD) | -5.69M | ||
| Weighted Average Shares | 10.64M | ||
| Weighted Average Shares Diluted | 10.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.13M | ||
| Cash and Equivalents (USD) | 3.13M | ||
| Current Assets | 5.67M | ||
| Property, Plant & Equipment Net | 6.00K | ||
| Total Assets | 8.16M | ||
| Current Liabilities | 13.21M | ||
| Total Liabilities | 13.47M | ||
| Accumulated Retained Earnings (Deficit) | -647.09M | ||
| Accumulated Other Comprehensive Income | -2.00K | ||
| Shareholders Equity | -5.31M | ||
| Shareholders Equity (USD) | -5.31M | ||
| Assets Non-Current | 2.49M | ||
| Goodwill and Intangible Assets | 2.48M | ||
| Liabilities Non-Current | 259.00K | ||
| Trade and Non-Trade Payables | 7.67M | ||
| Tax Assets | 1.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 44.00K | ||
| Net Cash Flow from Financing | 1.90M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -687.00K | ||
| Issuance (Purchase) of Equity Shares | 1.90M | ||
| Net Cash Flow from Operations | -2.58M | ||
| Effect of Exchange Rate Changes on Cash | -8.00K | ||
| Share Based Compensation | 634.00K | ||